These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25438464)

  • 41. [CAPS treatment].
    Jiménez Treviño S; Ramos Polo E
    Med Clin (Barc); 2011 Jan; 136 Suppl 1():29-33. PubMed ID: 21596184
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beyond the NLRP3 inflammasome: autoinflammatory diseases reach adolescence.
    Gattorno M; Martini A
    Arthritis Rheum; 2013 May; 65(5):1137-47. PubMed ID: 23400910
    [No Abstract]   [Full Text] [Related]  

  • 43. The pathogenesis of neonatal autoimmune and autoinflammatory diseases: a comprehensive review.
    Chang C
    J Autoimmun; 2013 Mar; 41():100-10. PubMed ID: 23375846
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Atypical presentation of a cryopyrin-associated periodic syndrome, revealing a novel NLRP3 mutation.
    Canouï E; Maigné G; Jéru I; Amselem S; Koné-Paut I; Lambotte O
    Clin Immunol; 2013 Aug; 148(2):299-300. PubMed ID: 23811320
    [No Abstract]   [Full Text] [Related]  

  • 45. Novel NLRP3/cryopyrin mutations and pro-inflammatory cytokine profiles in Behçet's syndrome patients.
    Yüksel Ş; Eren E; Hatemi G; Sahillioğlu AC; Gültekin Y; Demiröz D; Akdiş C; Fresko İ; Özören N
    Int Immunol; 2014 Feb; 26(2):71-81. PubMed ID: 24135410
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Significant effect of IL-1 receptor antagonist treatment in two patients who had CINCA syndrome with constant symptoms for 13 years].
    Idorn L; Vissing NH; Jensen L; Herlin T
    Ugeskr Laeger; 2012 May; 174(22):1537-8. PubMed ID: 22668652
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cryopyrin-associated periodic syndrome: a case report and review of the Japanese literature.
    Aoyama K; Amano H; Takaoka Y; Nishikomori R; Ishikawa O
    Acta Derm Venereol; 2012 Jul; 92(4):395-8. PubMed ID: 22377911
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors for severe Muckle-Wells syndrome.
    Kümmerle-Deschner JB; Tyrrell PN; Reess F; Kötter I; Lohse P; Girschick H; Huemer C; Horneff G; Haas JP; Koitschev A; Deuter C; Benseler SM
    Arthritis Rheum; 2010 Dec; 62(12):3783-91. PubMed ID: 20722029
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Inflammasome and interleukin 1].
    Jéru I; Amselem S
    Rev Med Interne; 2011 Apr; 32(4):218-24. PubMed ID: 20541850
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting IL-1beta in disease; the expanding role of NLRP3 inflammasome.
    Mitroulis I; Skendros P; Ritis K
    Eur J Intern Med; 2010 Jun; 21(3):157-63. PubMed ID: 20493414
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Good response to IL-1beta blockade by anakinra in a 23-year-old CINCA/NOMID patient without mutations in the CIAS1 gene. Cytokine profiles and functional studies.
    Hedrich CM; Fiebig B; Sallmann S; Bruck N; Hahn G; Roesler J; Roesen-Wolff A; Heubner G; Gahr M
    Scand J Rheumatol; 2008; 37(5):385-9. PubMed ID: 18609262
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An unusual phenotype in Muckle-Wells syndrome associated with NLRP3 E311K.
    Murphy G; Daly M; O'Sullivan M; Stack J; Rowczenio D; Lachmann H; Shanahan F; Harney S; Hawkins P; Molloy M
    Rheumatology (Oxford); 2011 Feb; 50(2):419-20. PubMed ID: 20819795
    [No Abstract]   [Full Text] [Related]  

  • 53. Cryopyrin-associated periodic syndromes: otolaryngologic and audiologic manifestations.
    Ahmadi N; Brewer CC; Zalewski C; King KA; Butman JA; Plass N; Henderson C; Goldbach-Mansky R; Kim HJ
    Otolaryngol Head Neck Surg; 2011 Aug; 145(2):295-302. PubMed ID: 21493283
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Corneal response to canakinumab in cryopyrin associated periodic fever syndrome.
    Tsatsos M; Hawkin PN; Hossain P
    Br J Ophthalmol; 2013 Aug; 97(8):1081-2. PubMed ID: 23740963
    [No Abstract]   [Full Text] [Related]  

  • 55. Treatment of autoinflammatory syndromes.
    Gattorno M; Martini A
    Curr Opin Pediatr; 2010 Dec; 22(6):771-8. PubMed ID: 20966753
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimens.
    Kuemmerle-Deschner JB; Wittkowski H; Tyrrell PN; Koetter I; Lohse P; Ummenhofer K; Reess F; Hansmann S; Koitschev A; Deuter C; Bialkowski A; Foell D; Benseler SM
    Arthritis Res Ther; 2013; 15(3):R64. PubMed ID: 23718630
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term clinical course of patients carrying the Q703K mutation in the NLRP3 gene: a case series.
    Vitale A; Lucherini OM; Galeazzi M; Frediani B; Cantarini L
    Clin Exp Rheumatol; 2012; 30(6):943-6. PubMed ID: 22935299
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rilonacept for the treatment of cryopyrin-associated periodic syndromes (CAPS).
    Hoffman HM
    Expert Opin Biol Ther; 2009 Apr; 9(4):519-31. PubMed ID: 19344287
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Cryopyrin-associated periodic syndromes (CAPS)].
    Yagüe J
    Med Clin (Barc); 2011 Jan; 136 Suppl 1():1-2. PubMed ID: 21596179
    [No Abstract]   [Full Text] [Related]  

  • 60. [IL-1 antagonists].
    Kötter I; Horneff G
    Z Rheumatol; 2010 Sep; 69(7):581-93. PubMed ID: 20703489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.